Neuracle博睿康

Develops NEO, a coin-sized implant placed in the skull, with eight electrodes resting on the dura, that drives a pneumatic glove to restore grasp after cervical spinal cord injury.

Interface category

Electrocorticography

Signal

Local field potentials, including high-gamma activity

Invasiveness

Minimally invasive

Recording / stimulation

Recording

Device

NEO — Wireless implant set into the skull, with electrodes resting on the dura; drives a pneumatic glove

Regulatory status

Registered by China's NMPA in March 2026 for a defined group of patients

Main use cases

Move, Control

Works with

Huashan Hospital, Fudan University · Xuanwu Hospital, Capital Medical University · Beijing Tiantan Hospital

Shown in people

A completed 32-participant registration trial, and registration by China's NMPA for assisted grasp after cervical spinal cord injury.

Still an aim

Wider indications. The registration covers one use, in adults aged 18 to 60.

What stands in the way

Published outcomes: the trial's results are not in a peer-reviewed journal, so the size of the benefit cannot be judged.

On record here: 1 registered study · 32 participants planned or enrolled · 0 peer-reviewed papers

• 13 Mar 2026China NMPA — Medical device registration. Adults aged 18 to 60 with tetraplegia from C2–C6 cervical spinal cord injury, for assisted grasp with a pneumatic glove. A marketing authorisation in China only.
• Aug 2024China NMPA — Special review procedure for innovative medical devices. A faster review route with closer contact with the regulator. It is not an authorisation.

NEO is the first implanted BCI that a regulator has cleared for sale, and it got there by asking for less. It sits outside the dura, records from few channels and does one thing: open and close a pneumatic glove. That is a narrower function than the cursor and speech systems in US feasibility studies, and a far more complete regulatory record. The registration trial's results have not been published in a peer-reviewed journal yet; they are what will show how much everyday function the grasp restores.

1. 11 Jun 2026

   The Shanghai Stock Exchange accepts the company's application to list on the STAR Market.

   Independent reporting财联社 (Cailian Press), carried by 21财经

2. 13 Mar 2026

   NMPA approves the registration of NEO as an implantable BCI system for hand motor function compensation.

   Independent reporting新浪财经 (Sina Finance)

3. Mar 2026

   Within days of the registration NEO is given a code in China's health-insurance system, a step toward reimbursement, according to MIT Technology Review.

   Independent reportingMIT Technology Review

4. 28 May 2025

   Multicentre registration trial of NEO begins; 32 participants enrolled, primary completion in November 2025.

   Clinical registryNEO · NCT06990412

5. Aug 2024

   NEO enters the NMPA's special review procedure for innovative medical devices.

   Independent reporting新浪财经 (Sina Finance)

6. 17 Oct 2023

   A first registered study of an implantable neural acquisition and stimulation system begins; nine participants planned.

   Clinical registryClinicalTrials.gov

• NEO

  Prospective multicentre trial of the NEO epidural BCI, run to support product registration in China.

  PivotalCompleted

  32 actualNCT06990412

• ECoGFeasibility

  Clinatec

  A French research centre developing wireless epidural recording implants.

• EndovascularFeasibility

  Synchron

  A BCI delivered through the blood vessels, without open brain surgery.

• IntracorticalClinical study

  StairMed

  An implanted intracortical BCI built on ultra-flexible electrodes, now in four registered clinical studies in China.

• ECoGApproved / cleared

  Precision Neuroscience

  A thin-film cortical surface array that slides under the skull through a narrow slit.

• Clinical · 8 Jul 2026

  China's BCI pipeline, counted for the first time